Search research articles
Contact Us
Filters
Showing results (141-150 of 303) with videos related to
Page
of 31
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2022
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
Sehhoon Park, Jae Myoung Noh, Yoon-La Choi, et al.
Future Oncology (London, England)
|
May 2, 2024
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma
Jong-Mu Sun, Antoine Adenis, Peter C Enzinger, et al.
Practical Radiation Oncology
|
April 22, 2026
The implication of failure patterns after neoadjuvant chemoradiotherapy with small involved field in esophageal squamous cell carcinoma
Hyunju Shin, Dongryul Oh, Jae Myoung Noh, et al.
Journal of Medical Internet Research
|
August 27, 2021
Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study
Kyungmi Yang, Dongryul Oh, Jae Myoung Noh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2025
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer
Joo-Young Byun, Jinyong Kim, Sehhoon Park, et al.
International Journal of Cancer
|
February 27, 2019
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Sun Hye Shin, Hye Yun Park, Yunjoo Im, et al.
Head & Neck
|
October 2, 2014
Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series
Sung Min Kim, Moon Jin Kim, Hyun Ae Jung, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2023
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
Hyunsu Kim, Sehhoon Park, Kyoung-Yeon Han, et al.
Pharmacogenomics
|
April 1, 2015
Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients
Hye In Woo, Jung A Kim, Hyun Ae Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho, Hae Su Kim, Bo Mi Ku, et al.
Page
of 31
Search research articles
Search
Showing results (141-150 of 303) with videos related to
Sort By:
Page
of 31
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2022
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
Sehhoon Park, Jae Myoung Noh, Yoon-La Choi, et al.
Future Oncology (London, England)
|
May 2, 2024
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma
Jong-Mu Sun, Antoine Adenis, Peter C Enzinger, et al.
Practical Radiation Oncology
|
April 22, 2026
The implication of failure patterns after neoadjuvant chemoradiotherapy with small involved field in esophageal squamous cell carcinoma
Hyunju Shin, Dongryul Oh, Jae Myoung Noh, et al.
Journal of Medical Internet Research
|
August 27, 2021
Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study
Kyungmi Yang, Dongryul Oh, Jae Myoung Noh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2025
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer
Joo-Young Byun, Jinyong Kim, Sehhoon Park, et al.
International Journal of Cancer
|
February 27, 2019
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Sun Hye Shin, Hye Yun Park, Yunjoo Im, et al.
Head & Neck
|
October 2, 2014
Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series
Sung Min Kim, Moon Jin Kim, Hyun Ae Jung, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2023
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
Hyunsu Kim, Sehhoon Park, Kyoung-Yeon Han, et al.
Pharmacogenomics
|
April 1, 2015
Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients
Hye In Woo, Jung A Kim, Hyun Ae Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2018
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho, Hae Su Kim, Bo Mi Ku, et al.
Page
of 31